Cargando…
Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study
BACKGROUND: Post-radiation nasopharyngeal necrosis (PRNN) is a severe adverse event following re-radiotherapy for patients with locally recurrent nasopharyngeal carcinoma (LRNPC) and associated with decreased survival. Biological heterogeneity in recurrent tumors contributes to the different risks o...
Autores principales: | Liu, Ting, Dong, Di, Zhao, Xun, Ou, Xiao-Min, Yi, Jun-Lin, Guan, Jian, Zhang, Ye, Xiao-Fei, Lv, Xie, Chuan-Miao, Luo, Dong-Hua, Sun, Rui, Chen, Qiu-Yan, Xing, Lv, Guo, Shan-Shan, Liu, Li-Ting, Lin, Da-Feng, Chen, Yan-Zhou, Lin, Jie-Yi, Luo, Mei-Juan, Yan, Wen-Bin, He, Mei-Lin, Mao, Meng-Yuan, Zhu, Man-Yi, Chen, Wen-Hui, Shen, Bo-Wen, Wang, Shi-Qian, Li, Hai-Lin, Zhong, Lian-Zhen, Hu, Chao-Su, Wu, De-Hua, Mai, Hai-Qiang, Tian, Jie, Tang, Lin-Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683300/ https://www.ncbi.nlm.nih.gov/pubmed/38012705 http://dx.doi.org/10.1186/s12916-023-03164-3 |
Ejemplares similares
-
Intratumoral and peritumoral radiomics analysis for preoperative Lauren classification in gastric cancer
por: Wang, Xiao-Xiao, et al.
Publicado: (2020) -
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial
por: Yuan, Li, et al.
Publicado: (2023) -
Loss of Cirbp expression is correlated with the malignant progression and poor prognosis in nasopharyngeal carcinoma
por: Lin, Tao-Yan, et al.
Publicado: (2019) -
Comparison of Gemcitabine Plus Cisplatin vs. Docetaxel Plus Fluorouracil Plus Cisplatin Palliative Chemotherapy for Metastatic Nasopharyngeal Carcinoma
por: Sun, Xue-Song, et al.
Publicado: (2020) -
Intensive Local Radiotherapy Is Associated With Better Local Control and Prolonged Survival in Bone-Metastatic Nasopharyngeal Carcinoma Patients
por: Li, Xiao-Yun, et al.
Publicado: (2020)